메뉴 건너뛰기




Volumn 105, Issue 3, 2010, Pages 314-316

Narrow-band imaging cystoscopy to evaluate the response to bacille Calmette-Guérin therapy: Preliminary Results: Preliminary

Author keywords

BCG; Bladder tumours; Cystoscopy; Narrow band imaging

Indexed keywords

BCG VACCINE;

EID: 75149153807     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08788.x     Document Type: Article
Times cited : (25)

References (8)
  • 1
    • 53849134494 scopus 로고    scopus 로고
    • A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences
    • Herr HW, Donat SM. A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. BJU Int 2008 102: 1111 1114
    • (2008) BJU Int , vol.102 , pp. 1111-1114
    • Herr, H.W.1    Donat, S.M.2
  • 2
    • 57449100062 scopus 로고    scopus 로고
    • New cystoscopic diagnosis for interstitial cystitis/painful bladder syndrome using narrow-band imaging system
    • Ueda T, Nakagawa M, Okamura M et al. New cystoscopic diagnosis for interstitial cystitis/painful bladder syndrome using narrow-band imaging system. Int J Urol 2008 15: 1039 1043
    • (2008) Int J Urol , vol.15 , pp. 1039-1043
    • Ueda, T.1    Nakagawa, M.2    Okamura, M.3
  • 3
    • 41149144274 scopus 로고    scopus 로고
    • Prognostic factors in patients with non-muscle-invasive bladder cancer treated with BCG: Multivariate analysis of data from four randomized CUETO trials
    • Fernandez-Gomez J, Solsona E, Unda M et al. Prognostic factors in patients with non-muscle-invasive bladder cancer treated with BCG: multivariate analysis of data from four randomized CUETO trials. Eur Urol 2008 53: 992 1002
    • (2008) Eur Urol , vol.53 , pp. 992-1002
    • Fernandez-Gomez, J.1    Solsona, E.2    Unda, M.3
  • 4
    • 61649110957 scopus 로고    scopus 로고
    • Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer
    • Lerner SP, Tangen CM, Sucharew H et al. Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer. Urol Oncol 2009 27: 155 159
    • (2009) Urol Oncol , vol.27 , pp. 155-159
    • Lerner, S.P.1    Tangen, C.M.2    Sucharew, H.3
  • 5
    • 0037404879 scopus 로고    scopus 로고
    • Defining BCG-refractory superficial bladder tumors
    • Herr HW, Dalbagni G. Defining BCG-refractory superficial bladder tumors. J Urol 2003 169: 1706 1708
    • (2003) J Urol , vol.169 , pp. 1706-1708
    • Herr, H.W.1    Dalbagni, G.2
  • 6
    • 39049137887 scopus 로고    scopus 로고
    • Routine transurethral biopsy of the bladder is not necessary to evaluate the response to BCG therapy
    • Murakami T, Ebara S, Saika T et al. Routine transurethral biopsy of the bladder is not necessary to evaluate the response to BCG therapy. Acta Med Okayama 2007 61: 341 344
    • (2007) Acta Med Okayama , vol.61 , pp. 341-344
    • Murakami, T.1    Ebara, S.2    Saika, T.3
  • 7
    • 0032832557 scopus 로고    scopus 로고
    • Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to BCG therapy?
    • Dalbagni G, Rechtschaffen T, Herr HW. Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to BCG therapy? J Urol 1999 162: 708 709
    • (1999) J Urol , vol.162 , pp. 708-709
    • Dalbagni, G.1    Rechtschaffen, T.2    Herr, H.W.3
  • 8
    • 0036167161 scopus 로고    scopus 로고
    • Routine bladder biopsy after BCG treatment: Is it necessary?
    • Skemp NM, Fernandes ET. Routine bladder biopsy after BCG treatment: is it necessary? Urology 2002 59: 224 226
    • (2002) Urology , vol.59 , pp. 224-226
    • Skemp, N.M.1    Fernandes, E.T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.